REG - Royal Bank of Canada - Notice of Publication of Amendments to Documents

Royal Bank of CanadaAnnouncement

08/12/2021 11:40

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211208:nRSH9826Ua&default-theme=true

RNS Number : 9826U  Royal Bank of Canada  08 December 2021

 

Royal Bank of Canada

8 December 2021

ROYAL BANK OF CANADA

(a Canadian chartered bank)

(the Issuer)

RBC COVERED BOND GUARANTOR LIMITED PARTNERSHIP

(the Guarantor LP)

 

NOTICE OF PUBLICATION OF AMENDMENTS TO THE SERIES CB35 FINAL TERMS AND
TRANSACTION DOCUMENTS

to the holders of the:

GBP650,000,000 Floating Rate Covered Bonds due December 8, 2022

(ISIN: XS1733227554) (Series: CB35)

 

 (the Series CB35 Covered Bonds or the Covered Bonds and the holders thereof,
the Covered Bondholders)

NOTICE IS HEREBY GIVEN THAT at the request of the Issuer, following the
passing of an Extraordinary Resolution on September 22, 2021 and as directed
by the Covered Bondholders, amendments have been made to:

(i)   the Final Terms relating to the Series CB35 Covered Bonds (as amended,
the Amended and Restated Series CB35 Final Terms);

 

(ii)   the Series CB35 Covered Bond Swap Confirmation (as amended, the
Amended and Restated Series CB35 Covered Bond Swap Confirmation); and

 

(iii)  the Trust Deed relating to the Series CB35 Covered Bonds (the
Supplemental Trust Deed).

These changes will be effective from December 8, 2021.

Capitalised terms used but not defined herein shall have the meanings set out
in the Notice of Meeting dated August 31, 2021 with respect to the Series CB35
Covered Bonds and the Consent Solicitation Memorandum of the Issuer dated
August 31, 2021.

 

To view the Amended and Restated Series CB35 Final Terms, the Amended and
Restated Series CB35 Covered Bond Swap Confirmation and the Supplemental Trust
Deed, please paste the following URL into the address bar of your browser:

 

https://www.rbc.com/investor-relations/covered-bonds.html#documents-content
(https://www.rbc.com/investor-relations/covered-bonds.html#documents-content)

 

For further information, please contact:

 

RBC Europe Limited

100 Bishopsgate

London

EC2N 4AA

United Kingdom

Attention: Liability Management Desk

Tel: +44 (0) 20 7029 7031

Email: liability.management@rbccm.com

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the
Amended and Restated Series CB35 Final Terms may be addressed to and/or
targeted at persons who are residents of particular countries only and is not
intended for use and should not be relied upon by any person outside these
countries and/or to whom this announcement and the Amended and Restated Series
CB35 Final Terms are not addressed.  Prior to relying on the information
contained in this announcement and the Amended and Restated Series CB35 Final
Terms, you must ascertain from the Consent Solicitation Memorandum dated
August 31, 2021 and the €32,000,000,000 Global Covered Bond Programme
Prospectus dated September 8, 2017 and the supplement to it dated December 1,
2017 (together, the Prospectus) whether or not you are one of the intended
addressees of the information contained in this announcement and the Series
CB35 Amended and Restated Final Terms.

In particular, this announcement and the Amended and Restated Series CB35
Final Terms do not constitute an offer or invitation to subscribe for, or
purchase, securities in the United States or in any other jurisdiction where
such an offer or invitation would be unlawful.  This announcement and the
Amended and Restated Series CB35 Final Terms are not for distribution in the
United States or to U.S. persons (as defined below).  The securities
described herein have not been, and will not be, registered under the U.S.
Securities Act of 1933, as amended (the Securities Act) or under any relevant
securities laws of any state of the United States of America and are subject
to U.S. tax law requirements.  The securities may not be offered or sold
within the United States or to, or for the account or benefit of, U.S. persons
or to persons within the United States of America (as such terms are defined
in Regulation S under the Securities Act) except pursuant to registration or
an exemption from the registration requirements of the Securities Act.  There
will be no public offering of the securities in the United States. For a
description of the restrictions on offers and sales of the securities
described herein, please refer to the Prospectus.

Your right to access this service is conditional upon complying with the above
requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPGAWPUPGGUR